Literature DB >> 19519613

Imipramine-induced hyperpigmentation: a case report and review of the literature.

Mark L D'Agostino1, Jessica Risser, Leslie Robinson-Bostom.   

Abstract

Imipramine-induced hyperpigmentation is rare with only 13 cases reported in the literature to date. We report a 64-year-old female who presented with blue-gray discoloration on her face present for 4-5 years. The patient's medications included imipramine for depression for approximately 23 years. Physical examination revealed slate-gray hyperpigmented discrete and coalescing macules of the malar cheeks and the bilateral temples and periorbitally. She also had diffuse gray pigmentation of the bilateral dorsal hands. Histologic examination revealed an unremarkable epidermis with golden-brown round globules clustered in the superficial dermis, which stained strongly positive with a Fontana-Masson stain. Prussian blue stain for hemosiderin was negative. A diagnosis of imipramine-induced hyperpigmentation was made. Imipramine-induced hyperpigmentation as well as a detailed review of drug-induced hyperpigmentation is discussed. (c) 2008 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519613     DOI: 10.1111/j.1600-0560.2008.01121.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Hydroxychloroquine-associated hyperpigmentation mimicking elder abuse.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2013-08-14

2.  Generalized and persistent skin pigmentation after COVID-19 vaccination.

Authors:  J Lu; Y Liu; Y Sun
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06-30       Impact factor: 9.228

3.  Melasma: A rare adverse effect of clomipramine.

Authors:  Sujita Kumar Kar
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.